Featured Research

from universities, journals, and other organizations

Brain Cell Transplants Potential Treatment For Multiple Sclerosis

Date:
November 1, 1999
Source:
American Neurological Association
Summary:
In an experiment that offers hope to patients with multiple sclerosis and similar disorders, scientists have managed to get transplanted brain cells to disperse and travel widely throughout the brain, according to a report in this month's Annals of Neurology, the scientific journal of the American Neurological Association and the Child Neurology Society.

In an experiment that offers hope to patients with multiple sclerosis and similar disorders, scientists have managed to get transplanted brain cells to disperse and travel widely throughout the brain, according to a report in this month's Annals of Neurology, the scientific journal of the American Neurological Association and the Child Neurology Society.

The results--in a rat model of Pelizaeus-Merzbacher disease, a rare, inherited childhood disorder--are a long way from being a therapy for human sufferers, but the research is a significant first step. "It shows proof-of-principle that generalized repair may be feasible using this approach," said Ian Duncan, BVMS, PhD, a researcher at the University of Wisconsin's School of Veterinary Medicine and senior author of the report.

Multiple sclerosis (MS) and related diseases involve damage to the nerves in the brain and spinal cord. Specifically, there is a loss, or failure of development, of myelin, a substance that normally insulates the nerves and speeds electrical conduction through the fibers. In the chronic myelin disorders, cells called oligodendrocytes, which produce the myelin, are either lost or genetically impaired.

In MS, for example, depending on which nerve fibers are hindered, patients can experience problems ranging from weakness and clumsiness to numbness, visual disturbances, and even emotional and intellectual changes. Some patients experience MS as cycles of relapse and remission; others progress to severe debilitation and may die from the disease.

In diseases such as Pelizaeus-Merzbacher, where myelin does not form properly, and a number of other inherited early childhood disorders where myelin is lost (e.g., Krabbe's disease and metachromatic leucodystrophy), the consequences are almost always disastrous, with children typically dying before the age of five. Pelizaeus-Merzbacher patients are exceptions in that they occasionally survive into their twenties, frequently with severe health problems.

One suggested path to treating chronic myelin disorders is to replace the defective oligodendrocytes with new ones. Duncan's group is of several that have worked for years trying to transplant cells into the spinal cords of particular rats and dogs called myelin mutants, whose gene defects lead to myelin diseases resembling the human disorders.

"We have succeeded in myelinating large areas of the spinal cord at the site of transplantation, but generalized spread of the implanted cells has proven elusive," said Duncan.

Duncan and his colleagues, first author Randy Learish, Ph.D., of the University of Wisconsin and Promega Corporation, Inc., of Madison, Wisconsin, and Oliver Brustle, M.D., of the University of Bonn Medical Center in Bonn, Germany, decided to try an approach pioneered by Brustle and others, though not with myelin-producing cells--they implanted the cells into the brain's ventricles.

The ventricles are a series of interconnected, irregular caverns within the brain, filled with cerebrospinal fluid (CSF). The CSF has been described as a "water jacket" that surrounds and helps stabilize the brain and spinal cord. It also helps maintain a constant chemical environment and removes waste products from the nervous system.

Along the edge of these reservoirs are the brain areas where cells are born and from which they migrate into the brain to perform various specialized functions within the different subdivisions of the brain.

The researchers harvested donor cells from the brains of normal rat fetuses and injected them into the ventricles of unborn rat embryos with a Pelizaeus-Merzbacher-like disorder.

They were heartened to find that the donor cells were not only accepted by the host brains, but they dispersed throughout the ventricles, entered the brain tissue, migrated to different brain areas, and began to produce myelin.

"What was particularly exciting was that you could deliver cells simply by delivering them to this general fluid depot in the brain," said Bruce Ransom, MD, PhD, chairman of neurology at the University of Washington and editor of Glia, a journal devoted to the study of supporting brain cells such oligodendrocytes.

Duncan provides a note of caution, however. "This study does not provide an immediate therapy for human Pelizaeus-Merzbacher patients, as the amount of myelin formed in the recipient rats was insufficient to improve the function or lifespan of the mutant."

But the results do show that the difficult task of transplanting cells in a disease where the damage is widespread is theoretically feasible.

The procedure is also promising for MS, says Duncan, because many of the damaged areas in that disease are near the ventricles. He stresses, however, that this work is at a very early stage.

"We need to be able to promote migration of a greater number of cells into the brain and have them myelinate many more nerve fibers. We also need to show that we can achieve similar results in the adult brain," he said.

Another potential challenge is posed by recent evidence that the nerve cell fibers (or axons) themselves may be damaged in diseases such as MS. "We used to just think of these as naked axons that couldn't function because they had lost their myelin wrap, but the truth that has been forced on us by excellent studies in the last year or two is that the demyelinated zones have a high percentage of ruptured axons," said Ransom.

It is possible, however, that mylenation by transplanted glial cells will protect axons against further loss and that the technique may help to partially relieve some symptoms of demyelinating diseases. Ransom predicts that remyelinating techniques will ready for trials in humans in the next decade.

Su-Chun Zhang, Ph.D., of the University of Wisconsin was also an author of the report.


Story Source:

The above story is based on materials provided by American Neurological Association. Note: Materials may be edited for content and length.


Cite This Page:

American Neurological Association. "Brain Cell Transplants Potential Treatment For Multiple Sclerosis." ScienceDaily. ScienceDaily, 1 November 1999. <www.sciencedaily.com/releases/1999/11/991101080431.htm>.
American Neurological Association. (1999, November 1). Brain Cell Transplants Potential Treatment For Multiple Sclerosis. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/1999/11/991101080431.htm
American Neurological Association. "Brain Cell Transplants Potential Treatment For Multiple Sclerosis." ScienceDaily. www.sciencedaily.com/releases/1999/11/991101080431.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins